Search results for "methadone"

showing 10 items of 48 documents

METHADONE VERSUS BUPRENORPHINE: DATA DETECTED FROM CALTANISSETTA SER.T

2018

In last years, heroin-addicted have exponentially increased: this has made it necessary to identify a pharmacological strategy as effective as possible. With this purpose, a statistical investigation was conducted in a sample of individuals, aged between 18 and 50. They were diagnosed and subjected to different treatments at Ser.T of Caltanissetta (Sicily-Italy) during the period 2013-2017. The analyzed patients were treated with three different pharmacological therapy: methadone 0.1%, methadone 0.5%, buprenorphine and suboxone. We obtained percentages of RESPONDERS, LOW RESPONDERS and NON RESPONDERS patients from data processing, based on used therapy. Considering pharmacological responses…

methadonesuboxoneSettore BIO/14 - Farmacologiabuprenorphine
researchProduct

Opioid Plasma Concentrations during a Switch from Transdermal Fentanyl to Methadone

2007

Opioid switching is often used to improve the opioid response in patients with cancer experiencing poor analgesia or adverse effects. When switching between drugs with delayed effect because of pharmacokinetics or type of delivery, concerns exist about the correct timing of introducing the second drug after stopping the previous one. The aim of this study was to assess plasmatic changes of fentanyl and methadone underlying the clinical events occurring during opioid switching. Eighteen patients with cancer receiving transdermal fentanyl with uncontrolled pain and/or moderate to severe opioid adverse effects, were switched to oral methadone using an initial fixed ratio of 1:20. Fentanyl patc…

AdultMaleTime FactorsPalliative careAdministration Cutaneousmethadone.Drug Administration ScheduleFentanylPharmacokineticsNeoplasmsHumansMedicineAdverse effectGeneral NursingAgedPain MeasurementTransdermalbusiness.industrywitchingPalliative CareOpioid plasma concentrationGeneral MedicineMiddle Agedtransdermal fentanylPain IntractableAnalgesics OpioidFentanylTreatment OutcomeAnesthesiology and Pain MedicineOpioidBasal (medicine)AnesthesiaFemalebusinessMethadonemedicine.drugMethadoneJournal of Palliative Medicine
researchProduct

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study

2001

PURPOSE: To evaluate the clinical benefits of switching from morphine to oral methadone in patients who experience poor analgesia or adverse effects from morphine. PATIENTS AND METHODS: Fifty-two consecutive cancer patients receiving oral morphine but with uncontrolled pain and/or moderate to severe opioid adverse effects were switched to oral methadone administered every 8 hours using different dose ratios. Intensity of pain and adverse effects were assessed daily, and the symptom distress score (DS) was calculated before and after switching. RESULTS: Data were analyzed for 50 patients. Switching was considered effective in 80% of the patients; results were achieved in an average of 3.65 …

MaleCancer ResearchAdministration OralPainDrug Administration ScheduleOral administrationNeoplasmsHumansMedicineProspective StudiesAdverse effectProspective cohort studyMorphinebusiness.industryMiddle AgedClinical trialAnalgesics OpioidProspective StudieOpioidTolerabilityOncologyAnesthesiaMorphineNeoplasmFemalebusinessMethadonemedicine.drugMethadoneHuman
researchProduct

Clinical management of drug-drug interactions in HCV therapy: Challenges and solutions.

2013

Contains fulltext : 118153.pdf (Publisher’s version ) (Open Access) Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other co-morbidities. Drug-drug interactions associated with this polypharmacy are relatively new to the field of HCV pharmacotherapy. With the advent of the direct-acting antivirals telaprevir and boceprevir, which are both substrates and inhibitors of the cytochrome P450 (CYP) 3A iso-enzyme, knowledge and awareness of drug-drug interactions have become a cornerstone in the evaluation of patients starting and continuing HCV combination therapy. In our opinion, an overview of conducted dr…

medicine.medical_specialtyCombination therapyPharmacologyAntiviral AgentsDrug interactionsTelaprevirTelaprevirchemistry.chemical_compoundPharmacotherapyAnti-Infective AgentsBoceprevirOpiate Substitution TreatmentmedicineHumansHypnotics and SedativesHypoglycemic AgentsPharmacokineticsSummary of Product CharacteristicsIntensive care medicineAdverse effectPolypharmacyBoceprevirHepatologybusiness.industryHCV therapyCardiovascular AgentsHepatitis C ChronicAntidepressive AgentsBuprenorphinechemistryCardiovascular agentHepatitis C virus infectionDrug Therapy CombinationHydroxymethylglutaryl-CoA Reductase InhibitorsPoverty-related infectious diseases Infectious diseases and international health [N4i 3]businessImmunosuppressive AgentsMethadonemedicine.drug
researchProduct

Slow release oral morphine versus methadone for the treatment of opioid use disorder

2019

ObjectiveTo assess the efficacy of slow release oral morphine (SROM) as a treatment for opioid use disorder (OUD).DesignSystematic review and meta-analysis of randomised controlled trials (RCTs).Data sourcesThree electronic databases were searched through 1 May 2018: the Cochrane Central Register of Controlled Trials, MEDLINE and EMBASE. We also searched the following electronic registers for ongoing trials: ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, Current Controlled Trials and the EU Clinical Trials Register.Eligibility criteria for selecting studiesWe included RCTs of all durations, assessing the effect of SROM on measures of treatment retention, heroin use…

Narcoticsmedicine.medical_specialtyAddictionAdministration OralCraving1681substance use treatmentHeroin03 medical and health sciences0302 clinical medicineSlow release oral morphine (SROM)Internal medicineOpiate Substitution TreatmentHumansMedicine1506030212 general & internal medicine10. No inequalityAdverse effectRandomized Controlled Trials as TopicMorphinebusiness.industryResearchsubstance misuseopioid use disorderOpioid use disorderGeneral MedicineOpioid-Related Disordersmedicine.disease3. Good healthmeta-analysisClinical trialoral morphineOpioid use disorderReducing heroin useDelayed-Action PreparationsMeta-analysisRelative riskmedicine.symptombusinessMethadone030217 neurology & neurosurgerymedicine.drugMethadoneBMJ Open
researchProduct

Occurrence of illicit drugs in two wastewater treatment plants in the South of Italy

2017

In this study the occurrence and the behavior of illicit drugs and their metabolites have been investigated for two wastewater treatment plants (WWTPs) (namely, WWTP-1 and WWTP-2) located in Sicily (island of Italy). Samples were analyzed for methamphetamine, cocaine (COC), 3,4-methylenedioxymethamphetamine (MDMA), methadone (METH), 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), 3,4-methylenedioxy amphetamine (MDA); 3,4-methylenedioxy ethylamphetamine (MDEA), 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH) and Benzoylecgonine (BEG). The BEG, COC, MOR and THC-COOH were found at the highest concentration in both WWTPs. The Wastewater-based epidemiology calculation for BEG, COC…

PyrrolidinesHealth Toxicology and Mutagenesis0208 environmental biotechnology02 engineering and technologyWastewater010501 environmental sciencesSettore MED/42 - Igiene Generale E ApplicataWaste Disposal Fluid01 natural sciencesMethamphetamineIllicit drugchemistry.chemical_compoundCocaineSettore BIO/10 - BiochimicaCannabidiolWater treatmentDronabinolSicilyDrug behavioreducation.field_of_studybiologyTraditional medicineChemistry (all)MDMAGeneral MedicineMethamphetaminePollutionContaminants of emerging concernSubstance Abuse DetectionDrug CombinationsBenzoylecgoninemedicine.drugEnvironmental EngineeringPopulationmedicineHumansEnvironmental Chemistryeducation0105 earth and related environmental sciencesSettore ICAR/03 - Ingegneria Sanitaria-AmbientaleIllicit Drugsbusiness.industryAmphetaminesCodeinePublic Health Environmental and Occupational HealthGeneral Chemistrybiology.organism_classificationEthylamphetamine020801 environmental engineeringAmphetaminechemistryCannabisbusinessWater Pollutants ChemicalMethadoneChemosphere
researchProduct

A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain

2002

A survey was carried out to evaluate the satisfaction with methadone treatment centres of methadone-maintained opioid-dependent patients from Spain. Independent interviewers asked 505 consecutively arriving clients from 20 randomly selected centres (14 conventional centres, two bus units, and four prisons) to participate; 370 (73.3%) clients agreed to fill out the questionnaire, and 351 (69.5%) completed it. Satisfaction was assessed using the Verona Service Satisfaction Scale for methadone treatment (VSSS-MT). The prison sub-sample (n=43) was excluded from overall analysis because survey acceptance and satisfaction was very different in prisons than in the other centres. Mean overall satis…

AdultMaleMental Health ServicesNarcoticsmedicine.medical_specialtyAdolescentService satisfactionPsychological interventionToxicologySurveys and QuestionnairesHumansMedicinePharmacology (medical)PsychiatryPharmacologyAnalysis of Variancebusiness.industryOpioid dependentRegression analysisMiddle AgedOpioid-Related DisordersPsychiatry and Mental healthPatient SatisfactionSpainFamily medicineFemaleSubstance Abuse Treatment CentersbusinessMethadoneMethadonemedicine.drugDrug and Alcohol Dependence
researchProduct

Intravenous Use of Methadone: Efficacy and Safety

2013

Parenteral methadone could be helpful in specific conditions, particularly in unstable conditions of when the oral route is unavailable. Intravenous methadone should be the preferred parenteral route, due to concerns about the local toxicity of subcutaneous route. This chapter assesses aspects regarding the pharmacokinetic issues, the clinical use, the problems associated with the use of intravenous methadone for chronic pain, as well as the perioperative use of intravenous methadone.

business.industryChronic painPerioperativemedicine.diseaseIntravenous usePharmacokineticsAnesthesiaToxicitymedicineOral routeCancer painbusinessMethadonemedicine.drug
researchProduct

The effect of age on opioid switching to methadone: a systematic review.

2012

The aim of this review was to assess from the existing literature the effect of age on the outcome of opioid switching to methadone, and the possible influence on conversions ratios.Older patients represent a challenge for physicians, as a further factor may play a role in dosing methadone and possibly on successful switching. Although existing data are not conclusive because this aspect did not receive particular attention in most studies, at the present time age has not been found to be independently associated with the dose ratio. Further prospective studies in a large sample of patients, subgrouped for classes of age, opioid doses, and reasons to switch, should be designed to provide mo…

medicine.medical_specialtybusiness.industryDrug SubstitutionAge FactorsPainGeneral MedicineAnalgesics OpioidAnesthesiology and Pain MedicineOpioidmedicineHumansPsychiatrybusinessGeneral NursingMethadoneMethadonemedicine.drugJournal of palliative medicine
researchProduct

Exercise as an Adjuvant Intervention in Opiate Dependence

2013

We read with interest the article by Weinstock et al. in whichthe authors propose exercise as an adjuvant intervention inopiate agonist treatment based on current research findings(1).The use of an opiate agonist, such as buprenorphine, butmainly, methadone, for the treatment of opiate dependenceis currently an effective therapy for this type of addiction.The main benefits of this treatment occur through a relieffrom craving narcotic drugs, a temporally suppression ofwithdrawal symptoms, and by blocking the euphoric effectsof opiates (2). Unfortunately, patients needing treatment foropiatedependenceoftenfaceavarietyofco-occurringissues,suchashepatitisBandCvirusesorhumanimmunodeficiencyvirus (H…

Agonistmedicine.medical_specialtymedicine.drug_classmedia_common.quotation_subjectMedicine (miscellaneous)CravingBioinformaticsHeroinOpiate Substitution TreatmentmedicineHumansPsychiatrymedia_commonbusiness.industryAddictionOpioid-Related Disordersmedicine.diseaseCombined Modality TherapyExercise TherapySubstance abusePsychiatry and Mental healthmedicine.symptomOpiatebusinessMethadonemedicine.drugBuprenorphineSubstance Abuse
researchProduct